Vergent Bioscience
Total Raised
$58.99MInvestors Count
8Deal Terms
1Funding, Valuation & Revenue
8 Fundings
Vergent Bioscience has raised $58.99M over 8 rounds.
Vergent Bioscience's latest funding round was a Series B - II for $18.67M on October 20, 2025.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/20/2025 | Series B - II | $18.67M | Orlando Health Ventures, and Rex Health Ventures | 1 | ||
2/18/2025 | Debt - II | |||||
11/29/2022 | Grant | |||||
10/4/2022 | Series B | |||||
11/22/2021 | Debt |
Date | 10/20/2025 | 2/18/2025 | 11/29/2022 | 10/4/2022 | 11/22/2021 |
|---|---|---|---|---|---|
Round | Series B - II | Debt - II | Grant | Series B | Debt |
Amount | $18.67M | ||||
Investors | Orlando Health Ventures, and Rex Health Ventures | ||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Vergent Bioscience Deal Terms
1 Deal Term
Vergent Bioscience's deal structure is available for 1 funding round, including their Series A from June 01, 2018.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Vergent Bioscience Investors
8 Investors
Vergent Bioscience has 8 investors. Rex Health Ventures invested in Vergent Bioscience's Series B - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/4/2022 | 10/20/2025 | 2 Series B, Series B - II (2025) | Corporate Venture | North Carolina | ||
Corporate Venture | Florida | |||||
Government | Maryland | |||||
Private Equity | New York | |||||
Venture Capital | New York |
First funding | 10/4/2022 | ||||
|---|---|---|---|---|---|
Last Funding | 10/20/2025 | ||||
Investor | |||||
Rounds | 2 Series B, Series B - II (2025) | ||||
Board Seats | |||||
Type | Corporate Venture | Corporate Venture | Government | Private Equity | Venture Capital |
Location | North Carolina | Florida | Maryland | New York | New York |
Loading...